Following the 2008 recession and heightened scrutiny over executive rewards, there is little surprise that total executive compensation for the executives in IBO’s annual executive compensation tables declined last year. In fiscal 2009, total average compensation for the 57 executives at 42 analytical instrument and laboratory product companies in IBO’s three Stock Indexes (see IBO […]
The gloom has lifted, according to the latest results of IBO’s Business Climate Survey. In contrast to the fall 2009 Business Climate Survey, conducted in October 2009 (see IBO 10/15/09), when 17% of respondents expected sales to decline in the next six months, not one Survey participant in this spring’s Survey expects sales to decline. […]
San Diego, CA 5/6/10; San Diego, CA 5/12/10—Sequenom has announced that it expects to raise $51.6 million through a private placement of common stock. The company has entered into an agreement to issue and sell 12,435,000 shares of common stock at $4.15 per share to certain investors. Earlier in the month, Sequenom announced it plans […]
Santa Clara, CA 5/14/10—Agilent Technologies has finalized its purchase of Varian for $1.5 billion in cash (see IBO 7/31/09). “The Varian acquisition—the largest in our company’s history—furthers our evolution toward becoming a global leader in bio-analytical measurement,” stated Agilent President and CEO Bill Sullivan. “We’re gaining tremendous talent and technology. And for our customers, this […]
Hercules, CA 5/4/10—Bio-Rad Laboratories has announced that as a result of an internal review it has identified conduct in certain overseas operations that may have violated the US Foreign Corrupt Practices Act’s (FCPA) antibribery provisions, books records and internal controls of the FCPA, and the company’s internal policies. Bio-Rad voluntarily disclosed these matters to the […]
Pay Invoice
Latest Blogs
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
-
Federal R&D Obligations for the NIH Decline in FY24
March 27, 2025 3:02 pm
-
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
February 26, 2025 1:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
